NEUROPHET, Inc. (KOSDAQ:380550)
South Korea · Delayed Price · Currency is KRW 8,000.00
+1,130.00 (16.45%)
Sep 21, 2026, 11:25 AM KST
NEUROPHET Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Cash & Equivalents | 3,804 | 4,102 | 3,017 |
Short-Term Investments | 41,716 | 19,667 | 3,000 |
Cash & Short-Term Investments | 45,520 | 23,768 | 6,017 |
Cash Growth | - | 295.00% | - |
Accounts Receivable | 342.28 | 223.17 | 353.94 |
Other Receivables | 422.91 | 226.49 | 96.29 |
Receivables | 765.19 | 449.67 | 450.23 |
Inventory | 68.23 | 47.24 | 10.86 |
Prepaid Expenses | 232.08 | 227.65 | 54.99 |
Other Current Assets | 727.62 | 521.61 | 354.34 |
Total Current Assets | 47,313 | 25,015 | 6,888 |
Property, Plant & Equipment | 1,199 | 1,275 | 1,992 |
Long-Term Investments | 900 | 0 | -0 |
Other Intangible Assets | 393.05 | 434.33 | 470.29 |
Other Long-Term Assets | 289.18 | 160.99 | 510.25 |
Total Assets | 50,095 | 26,884 | 9,860 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Accrued Expenses | 952.13 | 455.83 | 364.47 |
Short-Term Debt | - | 4,804 | 3,522 |
Current Portion of Leases | 286 | 686 | 625.07 |
Other Current Liabilities | 993.13 | 991.74 | 30,963 |
Total Current Liabilities | 2,231 | 6,937 | 35,474 |
Long-Term Leases | 36.14 | 40.56 | 665.06 |
Other Long-Term Liabilities | 6,304 | 454.44 | 616.24 |
Total Liabilities | 14,799 | 7,432 | 36,755 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Common Stock | 12,199 | 11,637 | 3,691 |
Additional Paid-In Capital | 112,089 | 85,611 | 105.01 |
Retained Earnings | -89,651 | -78,249 | -55,860 |
Comprehensive Income & Other | -36.38 | 453.81 | 867.16 |
Total Common Equity | 34,600 | 19,452 | -51,197 |
Shareholders' Equity | 35,296 | 19,452 | -26,895 |
Total Liabilities & Equity | 50,095 | 26,884 | 9,860 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Total Debt | 6,550 | 5,530 | 4,812 |
Net Cash (Debt) | 38,970 | 18,238 | 1,206 |
Net Cash Growth | - | 1412.64% | - |
Net Cash Per Share | 3321.94 | 1875.00 | 326.63 |
Filing Date Shares Outstanding | 12.2 | 11.64 | 3.69 |
Total Common Shares Outstanding | 12.2 | 11.64 | 3.69 |
Working Capital | 45,082 | 18,077 | -28,586 |
Book Value Per Share | 2836.36 | 1671.64 | -13869.37 |
Tangible Book Value | 34,207 | 19,018 | -51,667 |
Tangible Book Value Per Share | 2804.14 | 1634.32 | -13996.77 |
Machinery | 1,141 | 1,035 | 869.74 |